Strides Pharma Science
3
36M
2
0.10
1
0.33
1
- Areas of investment
Summary
The fund was located in Asia if to be more exact in India. The leading representative office of defined Corporate Investor is situated in the Bangalore.
The higher amount of exits for fund were in 2018. The important activity for fund was in 2017. The fund is generally included in less than 2 deals every year. Deals in the range of 50 - 100 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are Khattar Holdings, GMS Holdings, Agnus Capital.
Among the most popular portfolio startups of the fund, we may highlight Stelis Biopharma, Scootsy. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - India. We can highlight the next thriving fund investment areas, such as Food and Beverage, E-Commerce.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.10
- Follow on index
- 0.33
- Investments by industry
- Therapeutics (2)
- Life Science (2)
- Biotechnology (2)
- Biopharma (2)
- Food and Beverage (1) Show 5 more
- Investments by region
-
- India (3)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 81M
- Group Appearance index
- 1.00
- Avg. company exit year
- 3
- Avg. multiplicator
- 2.22
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Stelis Biopharma | 23 Nov 2018 | Biotechnology, Life Science, Therapeutics, Biopharma | Early Stage Venture | 35M | Karnataka, Bengaluru, India |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.